Diego B. Ortega-Zhindón

Dr. Diego B. Ortega-Zhindón

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2024 in Biology
Verified
Journal Article
Open access
PDF file
JCJORGE LUIS CERVANTES-SALAZAR
JORGE LUIS CERVANTES-SALAZAR
NPNonanzit Pérez-Hernández
Nonanzit Pérez-Hernández
JCJuan Calderón-Colmenero
Juan Calderón-Colmenero
JRJosé Manuel Rodríguez-Pérez
José Manuel Rodríguez-Pérez
MGMaria Guadalupe Gonzalez-Pacheco
Maria Guadalupe Gonzalez-Pacheco
DODiego B. Ortega-Zhindón
Diego B. Ortega-Zhindón
Congenital heart diseases (CHDs) are a group of complex diseases characterized by structural and functional malformations during development in the human heart; they represent an important problem for public health worldwide. Within these malformations, septal defects such as ventricular (VSD) and atrial septal defects (ASD) are the most common forms of CHDs. Studies have reported that CHDs are the result of genetic and environmental factors. Here, we review and summarize the role of genetics involved in cardiogenesis and congenital cardiac septal defects. Moreover, treatment regarding these congenital cardiac septal defects is also addressed.

31 May 2025 in Cells
Verified
Journal Article
Open access
PDF file
JRJosé Manuel Rodríguez-Pérez
José Manuel Rodríguez-Pérez
DODiego B. Ortega-Zhindón
Diego B. Ortega-Zhindón
CVClara Villamil-Castañeda
Clara Villamil-Castañeda
JOJavier Santiago Lara Ortiz
Javier Santiago Lara Ortiz
VBVerónica Borgonio-Cuadra
Verónica Borgonio-Cuadra
NPNonanzit Pérez-Hernández
Nonanzit Pérez-Hernández
Congenital Heart Diseases (CHDs) are a heterogeneous group of structural abnormalities affecting the heart and major arteries, which are present in at least 1% of births worldwide. Studies have linked CHD to both genetic and environmental factors. In this regard, it has been demonstrated that changes in the epigenetic pattern impact the expression of key genes involved in proper cardiac development. Therefore, it is suggested that aberrant epigenetic mechanisms may contribute to the development of these pathologies. Here, we review and summarize the main epigenetic mechanisms involved in CHD. Moreover, cardiac development and the importance of the environment and CHD are also addressed.

7 September 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
DODiego B. Ortega-Zhindón
Diego B. Ortega-Zhindón
JCJuan Calderón‐Colmenero
Juan Calderón‐Colmenero
JGJosé A. García‐Montes
José A. García‐Montes
JSJuan P. Sandoval
Juan P. Sandoval
MMMaría A. Minakata‐Quiroga
María A. Minakata‐Quiroga
JCJORGE LUIS CERVANTES-SALAZAR
JORGE LUIS CERVANTES-SALAZAR

21 June 2022 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
JCJorge L. Cervantes‐Salazar
Jorge L. Cervantes‐Salazar
JCJuan Calderón‐Colmenero
Juan Calderón‐Colmenero
AMAndrés Martínez‐Guzmán
Andrés Martínez‐Guzmán
JGJosé A. García‐Montes
José A. García‐Montes
FRFrida Rivera‐Buendía
Frida Rivera‐Buendía
DODiego B. Ortega-Zhindón
Diego B. Ortega-Zhindón

28 March 2022 in Archivos de Cardiología de México
Verified
Journal Article
Open access
DODiego B. Ortega-Zhindón
Diego B. Ortega-Zhindón
IFIris P. Flores-Sarria
Iris P. Flores-Sarria
MMMaría A. Minakata-Quiroga
María A. Minakata-Quiroga
SAStephanie T. Angulo-Cruzado
Stephanie T. Angulo-Cruzado
LRLuis A. Romero-Montalvo
Luis A. Romero-Montalvo
JCJORGE LUIS CERVANTES-SALAZAR
JORGE LUIS CERVANTES-SALAZAR
El isomorfismo cardiaco describe hallazgos anatómicos complejos con defectos en la determinación de la lateralización. Es una situación poco frecuente, con prevalencia de 1 en cada 10,000 a 20,000 nacidos vivos, con incidencia hasta del 4% de todas las malformaciones cardiacas. El diagnóstico puede realizarse en la etapa neonatal; sin embargo, el cuadro clínico es inespecífico. De acuerdo con el espectro de malformaciones se pueden necesitar medios diagnósticos complejos e invasivos. El tratamiento es variado y puede ir desde la cirugía paliativa en vista de una fisiología univentricular hasta una cirugía de corrección total para una reparación biventricular.

20 November 2023 in Diseases
Verified
Journal Article
Open access
PDF file
DODiego B. Ortega-Zhindón
Diego B. Ortega-Zhindón
NPNonanzit Pérez-Hernández
Nonanzit Pérez-Hernández
JRJosé Manuel Rodríguez-Pérez
José Manuel Rodríguez-Pérez
JGJosé A. García-Montes
José A. García-Montes
JCJuan Calderón-Colmenero
Juan Calderón-Colmenero
JCJORGE LUIS CERVANTES-SALAZAR
JORGE LUIS CERVANTES-SALAZAR
Right atrial isomerism (RAI) is a complex entity with varying diagnostic and treatment outcomes due to its rarity. Treatment options range from palliative to corrective surgeries, resulting in heterogeneous outcomes. The aim of this study was to analyze the results obtained after cardiac surgery in patients with RAI. A retrospective study was conducted, including patients diagnosed with RAI who underwent cardiac surgery. Their follow-up was from 1 January 2010 to 31 March 2020. Demographic characteristics and perioperative conditions were described. Thirty-eight patients were included, the median age was 4 years (IQR 2–9.2) and 57.9% were men. The main diagnoses were atrioventricular canal (63.2%) and pulmonary stenosis (55.3%). The most common surgical procedures were modified Blalock–Taussig shunt (65.8%) and total cavopulmonary connection with an extracardiac conduit fenestrated without cardiopulmonary bypass (15.9%). We did not find any factors associated with negative outcomes in these patients. The overall survival was 86.8%, with a better outcome in those who did not require reintubation (log rank, p < 0.01). The survival of RAI was similar to other centers. Individuals with RAI should be evaluated rigorously to determine an adequate repair strategy, considering high morbidity and mortality.